Detecting Alzheimer’s disease by a relatively inexpensive blood test could greatly reduce the cost of population screening and recruitment for […]
Month: November 2016
November 14, 2016 A BLOOD-BASED BIOMARKER MAY BE ABLE TO PREDICT ALZHEIMER’S DISEASE
November 3, 2016 WHAT ANTI-EPILEPTIC DRUGS ARE FDA-APPROVED FOR MONOTHERAPY?
Originally written: November 3, 2016 These are the FDA-Approved anti-epileptic drugs for monotherapy, the list is small: Felbamate for newly diagnosed […]